A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 41,537 shares of LLY stock, worth $38.6 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
41,537
Previous 42,100 1.34%
Holding current value
$38.6 Million
Previous $37.3 Million 14.03%
% of portfolio
0.91%
Previous 0.96%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$727.2 - $932.06 $409,413 - $524,749
-563 Reduced 1.34%
41,537 $32.1 Million
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $10.6 Million - $13.2 Million
-13,714 Reduced 24.57%
42,100 $37.3 Million
Q2 2024

Aug 08, 2024

SELL
$724.87 - $909.04 $1.13 Million - $1.42 Million
-1,565 Reduced 2.73%
55,814 $50.5 Million
Q1 2024

May 09, 2024

SELL
$592.2 - $792.28 $9.09 Million - $12.2 Million
-15,347 Reduced 21.1%
57,379 $44.6 Million
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $22.5 Million - $26.5 Million
-42,830 Reduced 37.06%
72,726 $42.4 Million
Q3 2023

Nov 02, 2023

SELL
$434.7 - $599.3 $3.71 Million - $5.11 Million
-8,525 Reduced 6.87%
115,556 $62.1 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $6.66 Million - $8.9 Million
-18,988 Reduced 13.27%
124,081 $58.2 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $2.76 Million - $3.24 Million
8,885 Added 6.62%
143,069 $49.1 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $10.8 Million - $12.6 Million
33,647 Added 33.47%
134,184 $49.1 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $3.98 Million - $4.53 Million
13,419 Added 15.4%
100,537 $32.5 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $17.8 Million - $20.8 Million
-63,684 Reduced 42.23%
87,118 $28.2 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $1.88 Million - $2.33 Million
-8,000 Reduced 5.04%
150,802 $43.2 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $2.66 Million - $3.3 Million
-11,827 Reduced 6.93%
158,802 $43.9 Million
Q3 2021

Nov 04, 2021

SELL
$221.6 - $272.71 $4.03 Million - $4.96 Million
-18,173 Reduced 9.63%
170,629 $39.4 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $7.48 Million - $9.67 Million
41,408 Added 28.09%
188,802 $43.3 Million
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $3.55 Million - $4.59 Million
-21,579 Reduced 12.77%
147,394 $27.5 Million
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $5.02 Million - $6.64 Million
38,446 Added 29.45%
168,973 $28.5 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $3.14 Million - $3.64 Million
21,507 Added 19.73%
130,527 $19.3 Million
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $1.58 Million - $1.9 Million
-11,575 Reduced 9.6%
109,020 $17.9 Million
Q1 2020

May 08, 2020

SELL
$119.05 - $147.35 $9.69 Million - $12 Million
-81,404 Reduced 40.3%
120,595 $16.7 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $1.55 Million - $1.92 Million
-14,529 Reduced 6.71%
201,999 $26.5 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $2.25 Million - $2.45 Million
21,057 Added 10.77%
216,528 $24.2 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $12.9 Million - $15 Million
116,027 Added 146.05%
195,471 $21.7 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $473,401 - $557,228
-4,253 Reduced 5.08%
79,444 $10.3 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $1.99 Million - $2.23 Million
18,812 Added 28.99%
83,697 $9.69 Million
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $644,509 - $739,696
-8,514 Reduced 11.6%
64,885 $5.54 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $1.52 Million - $1.8 Million
-20,533 Reduced 21.86%
73,399 $5.68 Million
Q4 2017

Feb 13, 2018

BUY
$81.94 - $87.89 $2.44 Million - $2.61 Million
29,730 Added 46.31%
93,932 $7.93 Million
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $4.95 Million - $5.49 Million
64,202
64,202 $5.49 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $883B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.